Survival regression for T
(R,D)
in the AML-MDS trial. Panels (a)–(d) show the posterior estimated
survival functions for a future patient at age 61 with poor prognosis
cytogenetic abnormality, with T
(0,R) and
Z2,1 as indicated. Survival curves are shown for
four induction therapies. Black, red, green and blue curves indicate
Z1 = FAI, FAI+ATRA,
FAI+GCSF and FAI+ATRA+GCSF, respectively.